Immunology Market Size and Share | Industry Report 2035

Introduction:

The Global Immunology Market is witnessing significant growth, driven by the increasing prevalence of autoimmune and chronic inflammatory diseases, advancements in biotechnology and molecular biology, rising adoption of targeted therapies, increasing use of biosimilars, and growing investment in research and development. Immunology treatments play an important role in managing conditions such as rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, and inflammatory bowel disease. Advancements in personalized medicine, biologics, gene therapies, and innovative drug development are further supporting market expansion worldwide.

Get Free Sample of This Premium Report: https://www.decisionsadvisors.com/request-sample/DAR4641

Global Immunology Market Insights

• Based on Decision Advisors findings, the Global Immunology Market was valued at USD 110.25 Billion in 2024 and is projected to reach USD 295.65 Billion by 2035.
• From 2026 to 2035, the global market is expected to grow at a CAGR of 10.37%.
• Within the Drug Class category, Monoclonal Antibody (mAb) accounted for the largest market share in 2025, at approximately 64.75%.
• Within the Disease Indication category, Rheumatoid Arthritis accounted for the largest market share in 2025, at approximately 33.85%.

Other Key Findings

• North America accounted for the largest share of the Global Immunology Market in 2025, supported by advanced healthcare infrastructure, high healthcare expenditure, strong pharmaceutical and biotechnology presence, and extensive research and development activities.
• Asia Pacific is expected to be the fastest-growing regional market during the forecast period, driven by increasing healthcare expenditure, rising prevalence of autoimmune and infectious diseases, improving healthcare infrastructure, and expanding access to advanced therapies.
• Europe represented the third-largest regional market during the forecast period, supported by established healthcare systems, pharmaceutical and biotechnology companies, and active research activities.
• Increasing adoption of biosimilars, personalized medicine, advanced diagnostics, artificial intelligence, and targeted immunotherapies is expected to create new opportunities for market participants.

Report Summary

Want detailed insights, forecasts, and competitive analysis?

Check out the full report now: https://www.decisionsadvisors.com/reports/immunology-market